Meihao Medical Group (HKG:1947) expects a net loss of between 29.4 million yuan and 35.9 million yuan for the year 2024, wider than the 13.6 million loss a year prior, a Thursday filing with the Hong Kong bourse said.
The medical equipment manufacturer attributed the anticipated loss mainly to a significant decline in its sales price leading to a lower profit margin from implant dentistry services, intense competition, lower consumer spending, and higher staff costs.
Price (HKD): $0.34, Change: $-0.020, Percent Change: -5.56%
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。